Clinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin Therapy | Zendy

A. Mykietiuk | Zendy; Jordi Carratalà | Zendy; Núria Sabé | Zendy; Jordi Dorca | Zendy; R. Verdaguer | Zendy; F. Manresa | Zendy; F. Gudiol | Zendy

Open Access

Clinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin Therapy

Author(s) -

A. Mykietiuk,

Jordi Carratalà,

Núria Sabé,

Jordi Dorca,

R. Verdaguer,

F. Manresa,

F. Gudiol

Publication year - 2005

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/428059

Subject(s) - medicine , levofloxacin , pneumonia , case fatality rate , legionella , community acquired pneumonia , erythromycin , clarithromycin , antibiotics , surgery , epidemiology , microbiology and biotechnology , genetics , bacteria , biology , helicobacter pylori

Although the reduction in case-fatality rate recently observed among patients with Legionella pneumonia has been largely attributed to the progressive utilization of urine antigen testing, other factors, such as changes in empirical antibiotic therapy, may also have contributed. We have analyzed more-recent outcomes of Legionella pneumonia in an institution where urine antigen testing was reflexly performed in cases of community-acquired pneumonia without an etiological diagnosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research